NECA CEO Meredith Cummins is Now INCA President
February 16, 2026
We are proud to share that our CEO, Meredith Cummins, has been appointed President of the International Neuroendocrine Cancer Alliance (INCA). Meredith has served on
Meredith Cummins is CEO of NeuroEndocrine Cancer Australia and incoming President of the International Neuroendocrine Cancer Alliance, representing patient advocacy groups worldwide. Every World Cancer
NECA was invited to participate and co-author in a multidisciplinary working group to conduct a systematic review and meta-analysis to evaluate the current evidence on
The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital,